AKT1 and glioblastoma: In glioblastoma, nobiletin (15 μM) suppressed migration and invasion by blocking TGF-β-induced β-catenin nuclear translocation via inhibition of the AKT/GSK3β/β-catenin signaling pathway (Figure 5) [121].